- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07289685
Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery
This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement.
Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. The goal is to find out if early walking can reduce the chances of complications, shorten hospital stays, and lower medical costs.
Participants will start wearing the device after surgery and continue for about 7 days or until they leave the hospital. During this time, they will also fill out a simple daily observation form. Participation is voluntary, and patients can withdraw at any time without affecting their care.
The study hopes to provide new ways to improve recovery and offer better support to patients after colorectal surgery.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Taoyuan District, Taiwan, 333
- Chang Gung Memorial Hospital, Linkou
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients undergoing minimally invasive colorectal tumor resection.
- Aged 20 to 85 years.
- ECOG score 0-2.
- Clear consciousness and ability to communicate in Mandarin or Taiwanese (or via family translation).
- Informed consent provided by the patient or family.
Exclusion Criteria:
- Patients with acute/chronic psychiatric disorders or cognitive impairment.
- Patients undergoing traditional open or local resection surgeries.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Postoperative Colorectal Cancer Patients with Wearable Device Monitoring
Patients diagnosed with colorectal cancer who underwent minimally invasive surgery.
Participants wore a wrist-worn device to monitor postoperative physical activity, heart rate, and sleep for up to 7 days or until discharge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Length of Stay
Time Frame: Through hospital discharge (an average of 7 days after surgery)
|
The number of calendar days from the date of colorectal surgery to the date of hospital discharge, recorded from the hospital electronic medical record.
|
Through hospital discharge (an average of 7 days after surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Complications (Clavien-Dindo classification)
Time Frame: Postoperative Day 30
|
The occurrence and severity of postoperative complications during hospitalization, graded using the Clavien-Dindo classification system based on medical record review.
|
Postoperative Day 30
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202102412B0
- CMRPG3M2171 (Other Grant/Funding Number: Chang Gung Memorial Hospital, Linkou)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.